Jul
16
2026
July 16, 2026
ISN Western Europe Regional Board Webinar: Implementing the New KDIGO IgA Nephropathy Guidelines – Translating Evidence, Innovation, and Access into Clinical Practice
- 4 PM CET
The management of IgA nephropathy (IgAN) is evolving rapidly, driven by the publication of updated KDIGO guidance and the emergence of novel targeted therapies. This webinar will provide a practical overview of key recommendations from the latest KDIGO IgAN guidelines, review the evidence supporting new and emerging treatment options, and explore challenges related to access, regulatory approvals, and implementation in clinical practice. Expert faculty will also discuss pediatric considerations and regional perspectives on translating guideline recommendations into equitable patient care across Europe.
Learning objectives:
- Review the key updates and clinical implications of the latest KDIGO IgA nephropathy guidelines.
- Evaluate the efficacy, safety, regulatory status, and access considerations of new and emerging therapies for IgA nephropathy.
- Identify practical strategies to implement guideline-based care across diverse healthcare settings, including pediatric populations and regional healthcare systems.
Moderator
Maria Jose Soler (Spain)
David Wheeler (UK)
Speakers
Jonathan Barratt (UK)
Marina Vivarelli (Italy)
Jurgen Floege (Germany)